ULBP3 (2F9) Antibody sc-53132 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemULBP3 (2F9) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-53132
Antibody TypePrimary Antibodies
NCBI Gene AliasesN2DL-3, NKG2DL3, RAET1N
Clone2F9
Quantity200 µg/ml
Reactivityhuman
ApplicationsIF, FCM
Conjugate/TagUnconjugated
ClonalityMonoclonal
FormatPurified
Hostmouse
NCBI Full Gene NameUL16 binding protein 3
TargetULBP3
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cellsPharm BiolDecember 1, 2021Ng W, Gong C, Yan X, Si G, Fang C, Wang L, Zhu X, Xu Z, Yao C, Zhu S.ULBP2 (Santa Cruz Biotechnology, Dallas, TX, sc-80419), ULBP3 (Santa Cruz Biotechnology, Dallas, TX, sc-53132), ULBP4 (Santa Cruz Biotechnology, Dallas, TX, sc-53133) and ULBP5 (Santa Cruz Biotechnology, Dallas,

(2) MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cellsMolecular medicine reportsJanuary 1, 2019Luo D, Dong XW, Yan B, Liu M, Xue TH, Liu H, You JH, Li F, Wang ZL, Chen ZN.(catalog no. sc-80527), ULBP1 (catalog no. sc-53131), ULBP2 (catalog no. sc-53135), ULBP3 (catalog no. sc-53132) and ULBP4 (catalog no. sc-53133) monoclonal antibodies (mAbs) were purchased from Santa Cruz Biotechnology, Inc

(3) Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagyAutophagyJanuary 1, 2018Yao C, Ni Z, Gong C, Zhu X, Wang L, Xu Z, Zhou C, Li S, Zhou W, Zou C, et al.

(4) NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AMLJournal of immunology researchJanuary 1, 2015Schlegel P, Ditthard K, Lang P, Mezger M, Michaelis S, Handgretinger R, Pfeiffer M.

(5) Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibitionHuman gene therapyMarch 1, 2013Song DG, Ye Q, Santoro S, Fang C, Best A, Powell DJ Jr.

(6) Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage LeukemiaFrontiers in oncologyJanuary 1, 2013Pfeiffer MM, Burow H, Schleicher S, Handgretinger R, Lang P.

(7) Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrenceJournal of hepatologyFebruary 1, 2012Kamimura H, Yamagiwa S, Tsuchiya A, Takamura M, Matsuda Y, Ohkoshi S, Inoue M, Wakai T, Shirai Y, Nomoto M, et al.

(8) Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cellsCancer researchMarch 1, 2011Bedel R, Thiery-Vuillemin A, Grandclement C, Balland J, Remy-Martin JP, Kantelip B, Pallandre JR, Pivot X, Ferrand C, Tiberghien P, et al.

(9) Genome-wide association study in alopecia areata implicates both innate and adaptive immunityNatureJuly 1, 2010Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, et al.

Be the First to Write a Review!

ULBP3 (2F9) Antibody

ULBP3 (2F9) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (9)

Reviews

ULBP3 (2F9) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map